Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis

被引：0
|
作者：
Quan Rao
Min Li
Wei Xu
Kai Pang
XiaoBo Guo
Dong Wang
Jun Liu
Wei Guo
ZhongTao Zhang
机构：
[1] Capital Medical University,Department of General Surgery, Beijing Friendship Hospital
[2] Beijing Key Laboratory of Cancer Invasion and Metastasis Research and National Clinical Research Center for Digestive Diseases,Clinical Epidemiology and EBM Unit, National Clinical Research Center for Digestive Disease, Beijing Friendship Hospital
[3] Capital Medical University,Department of Vascular Surgery, Beijing Friendship Hospital
[4] Capital Medical University,undefined
来源：
Hepatology International | 2020年 / 14卷
关键词：
PD-1; PD-L1; Monoclonal antibody; Nivolumab; Pembrolizumab; Anti-VEGF agent; Objective response rate; Disease control rate; Overall survival; Progression-free survival; Adverse event; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：765 / 775
页数：10
相关论文
共 50 条
  • [31] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [32] Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis
    Ma, K.
    Guo, Y.
    Wang, Y.
    Wang, X.
    Xu, Y.
    Sun, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S584 - S584
  • [33] The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
    Zi-Lu Huang
    Shan Liu
    Guan-Nan Wang
    Shuo-Han Zheng
    Shi-Rong Ding
    Ya-lan Tao
    Chen Chen
    Song-Ran Liu
    Xin Yang
    Hui Chang
    Xiao-Hui Wang
    Yun-Fei Xia
    [J]. Cancer Cell International, 19
  • [34] The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
    Huang, Zi-Lu
    Liu, Shan
    Wang, Guan-Nan
    Zheng, Shuo-Han
    Ding, Shi-Rong
    Tao, Ya-lan
    Chen, Chen
    Liu, Song-Ran
    Yang, Xin
    Chang, Hui
    Wang, Xiao-Hui
    Xia, Yun-Fei
    [J]. CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [35] The Prognostic Significance of PD-L1 and PD-1 Expression in Patients with Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
    Huang, Z.
    Shan, L.
    Zheng, S. H.
    Wang, G.
    Ding, S. R.
    Tao, Y. L.
    Chen, C.
    Yang, X.
    Liu, S. R.
    Xia, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E437 - E437
  • [36] Efficacy of PD-1 and PD-L1 inhibitors in older adults: A meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    Rahma, Osama E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    McCleary, Nadine Jackson
    Ott, Patrick
    Hodi, F. Stephen
    Rahma, Osama
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [38] Association of PD-L1 expression status with the efficacy of PD-1/PD-L1 inhibitors and overall survival in solid tumours: A systematic review and meta-analysis
    Liu, Xi
    Guo, Chang-Ying
    Tou, Fang-Fang
    Wen, Xiao-Ming
    Kuang, Yu-Kang
    Zhu, Qian
    Hu, Hao
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 116 - 127
  • [39] PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
    Gandini, Sara
    Massi, Daniela
    Mandala, Mario
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 100 : 88 - 98
  • [40] Efficacy of PD-1/PD-L1 inhibitors in advanced gastroesophageal cancer based on characteristics: a meta-analysis
    Liu, Wenjie
    Huo, Gengwei
    Chen, Peng
    [J]. IMMUNOTHERAPY, 2023, 15 (10) : 751 - 771
12345